Progress in determining the malignant potential of oral lesions

10.1016/0360-3016(89)90096-5

10.1016/S1368-8375(00)00045-2

Lotan R., 2000, Are we ready to use surrogate end points and surrogate tissues to evaluate response to chemopreventive and therapeutic intervention?, Clin Cancer Res, 6, 2126

Kopelovich L, 1999, Surrogate anatomic/functional sites for evaluating cancer risk: an extension of the field effect, Clin Cancer Res, 5, 3899

10.1056/NEJM199301213280306

10.1056/NEJMra001375

10.1016/S0901-5027(89)80117-1

10.1111/j.1600-0528.1980.tb01302.x

10.1002/1097-0142(19860215)57:4<843::AID-CNCR2820570426>3.0.CO;2-W

10.1016/S1368-8375(00)00006-3

10.1002/1097-0142(197510)36:4<1386::AID-CNCR2820360430>3.0.CO;2-7

10.1002/1097-0142(197509)36:3<1021::AID-CNCR2820360327>3.0.CO;2-W

10.1002/1097-0142(197312)32:6<1436::AID-CNCR2820320622>3.0.CO;2-C

10.1056/NEJM197707142970212

10.1016/0030-4220(88)90166-1

Bouquot JE., 1994, Oral leukoplakia and erythroplakia: a review and update, Pract Periodont Aesthet Dent, 6, 9

10.1016/S0968-6053(05)80014-6

Lind PO., 1987, Malignant transformation in oral leukoplakia, Scand J Dent Res, 95, 449

Lee JJ, 2000, Predicting cancer development in oral leukoplakia: 10 years of translational research, Clin Cancer Res, 6, 1702

10.1002/1097-0142(19840201)53:3<563::AID-CNCR2820530332>3.0.CO;2-F

10.1016/S1368-8375(98)80007-9

10.3109/00016356309028203

10.1016/0030-4220(86)90422-6

Feller L, 1991, Pre‐malignant lesions of the oral mucosa in a South African sample – a clinicopathological study, J Dent Assoc S Afr, 46, 261

10.1002/1097-0142(19890601)63:11<2247::AID-CNCR2820631132>3.0.CO;2-D

10.1111/j.1600-0714.1995.tb01166.x

10.1016/S1079-2104(05)80201-X

10.1016/S1368-8375(00)00057-9

10.1054/bjoc.1999.1130

10.1016/S1079-2104(05)80226-4

10.1016/0030-4220(89)90307-1

10.1111/j.1600-0714.1993.tb01066.x

10.1056/NEJM200104263441702

10.1002/1096-9896(200107)194:3<303::AID-PATH879>3.0.CO;2-Q

10.1056/NEJM199502163320704

10.1007/BF00049484

10.1056/NEJM200104263441710

10.1038/nrc755

10.1016/S1368-8375(00)00007-5

10.1016/S1368-8375(00)00021-X

10.1016/S1368-8375(00)00023-3

10.1002/(SICI)1096-9896(200003)190:4<407::AID-PATH546>3.0.CO;2-D

10.1002/1096-9896(200107)194:3<294::AID-PATH911>3.0.CO;2-Q

10.1126/science.278.5340.1054

Spafford MF, 2001, Detection of head and neck squamous cell carcinoma among exfoliated oral mucosal cells by microsatellite analysis, Clin Cancer Res, 7, 607

10.1093/jnci/91.7.599

10.1002/1097-0142(20011101)92:9<2349::AID-CNCR1582>3.0.CO;2-I

Rosin MP, 2000, Use of allelic loss to predict malignant risk for low‐grade oral epithelial dysplasia, Clin Cancer Res, 6, 357

10.1038/nm0696-682

10.1002/1097-0142(20010601)91:11<2148::AID-CNCR1243>3.0.CO;2-G

Guo Z, 2001, Allelic losses in OraTest‐directed biopsies of patients with prior upper aerodigestive tract malignancy, Clin Cancer Res, 7, 1963

10.1093/jnci/85.23.1951

Shin DM, 2001, p53 protein accumulation and genomic instability in head and neck multistep tumorigenesis, Cancer Epidemiol Biomarkers Prev, 10, 603

Voravud N, 1993, Increased polysomies of chromosomes 7 and 17 during head and neck multistage tumorigenesis, Cancer Res, 53, 2874

Kim J, 2001, Chromosome polysomy and histological characteristics in oral pre‐malignant lesions, Cancer Epidemiol Biomarkers Prev, 10, 319

Singh B, 2002, Genome wide screening identified gains and losses as independent prognostic variables in patients with head and neck squamous cell carcinomas (HNSCC), J Clin Oncol, 21, 233

10.1002/(SICI)1096-9896(200003)190:4<417::AID-PATH544>3.0.CO;2-G

10.1111/j.1834-7819.1999.tb00209.x

10.1016/S1368-8375(00)00092-0

10.1097/00001622-200001000-00014

10.1200/JCO.20.2.456

Partridge M, 2000, A case‐control study confirms that microsatellite assay can identify patients at risk of developing oral squamous cell carcinoma within a field of cancerization, Cancer Res, 60, 3893